ERBB2 and gastric cancer: However, as intra- or inter-tumoral heterogeneity of HER2 expression in gastric cancer is well known to cause false-negative interpretation [7–9, 16–19], more assiduous tissue analysis is required to increase the possibility of detecting HER2 positivity.